ENDRA Life Sciences NDRA
NASDAQ NDRA
$4.68 +0.27 (+6.24%)
As of: Oct 21, 2026 · 3:57 PM EDT

ENDRA Life Sciences (NDRA) Cash from Financing Activities (2016 - 2026)

Updated

ENDRA Life Sciences' Cash from Financing Activities came in at $3.89 million for Q2 2026, up 354.1% from $857,415 a year earlier.

Analysis

ENDRA Life Sciences (NDRA) Cash from Financing Activities (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, ENDRA Life Sciences reported Cash from Financing Activities of $8.89 million, up 784.4% year-over-year; for FY2025, it was $5.73 million, down 26.6% from FY2024.

  • Cash from Financing Activities carries a five-year compound annual growth rate of -13.6% (FY2020 to FY2025).
  • Going back by year, Cash from Financing Activities was $7.81 million in FY2024 (+3.9%), $7.52 million in FY2023 (-10.5%), $8.4 million in FY2022 (-37.3%) and $13.4 million in FY2021 (+12.9%).
  • The five-year range for quarterly Cash from Financing Activities is $1,683 (Q3 2024) to $7.55 million (Q2 2022).
  • Year-over-year, Cash from Financing Activities increased in two of the last five quarters, with growth averaging 35.6%.
  • The fastest year-over-year change in Cash from Financing Activities over five years came in Q2 2026 (growth of 354.1%), and the weakest in Q3 2024 (a decline of 99.8%).
  • Business Quant data shows NDRA's Cash from Financing Activities at $263,747 (Q1 2026), $4.58 million (Q4 2025) and $149,466 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn -1.57 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn -3.52 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 7.27 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn -287.90 Mn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn -343.00 Mn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn -95.00 Mn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn -410.00 Mn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn -577.00 Mn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn -300,000.00
10 ENDRA Life Sciences 6.18 Mn 2.53 Mn - 3.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.89 Mn
Mar 31, 2026 263,747.00
Dec 31, 2025 4.58 Mn
Sep 30, 2025 149,466.00
Jun 30, 2025 857,415.00
Mar 31, 2025 145,803.00
Sep 30, 2024 1,683.00
Jun 30, 2024 7.34 Mn
Mar 31, 2024 468,902.00
Dec 31, 2023 1.67 Mn
Sep 30, 2023 1.11 Mn
Jun 30, 2023 4.73 Mn
Jun 30, 2022 7.55 Mn
Mar 31, 2022 854,052.00
Dec 31, 2021 321,076.00
Sep 30, 2021 496,606.00
Mar 31, 2021 12.58 Mn
Dec 31, 2020 5.57 Mn
Sep 30, 2020 5.17 Mn
Jun 30, 2020 1.10 Mn
API Access

ENDRA Life Sciences Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NDRA&period=max&api_key=YOUR_API_KEY